Esperion Therapeutics, Inc.
ESPRNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Jul 14, 2026 close
- Market cap
- $799.30M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- 99.37%
- 52-week range
- $1.80$4.18
- Volume (live)
- -
- Avg. volume (3M)
- -
Esperion Therapeutics (ESPR) Stock Price & Financial Analysis
Esperion Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.18 - $3.18 |
|---|---|
| 52-Week High | $4.18 |
| 52-Week Low | $1.80 |
| Open | $3.18 |
| Revenue (TTM) | 418.24M |
|---|---|
| Net Income (TTM) | -7.42M |
| Free Cash Flow (TTM) | -18.19M |
| EPS (TTM) | −$0.03 |
| Profit Margin | -1.77% |
| Operating Margin | 18.12% |
| Annual Dividend | $3.16 |
|---|---|
| Dividend Yield | 99.37% |
| Last Dividend Ex-Date | Jul 13, 2026 |
| Market Cap | 799.30M |
|---|---|
| Shares Outstanding | 251.35M |
| Price to Sales (P/S) | 1.91 |
| Price to Book (P/B) | -2.60 |
| EV/EBITDA | 30.30 |
| 50-Day MA | $3.14 |
|---|---|
| 200-Day MA | $3.06 |
| 1-Year Change | +15.64% |
Source: Market prices and company fundamentals. Data as of Jul 14, 2026. Data sources and methodology
Esperion Therapeutics at a Glance
As of the Jul 14, 2026 close, Esperion Therapeutics (ESPR) has a market capitalization of $799.30M. The stock trades at 1.9× sales. Over the trailing twelve months it lost $7.42M on revenue of $418.24M and burned $18.19M of free cash flow. Revenue grew 61.1% year over year.
As of its latest reported balance sheet, it holds $156.16M in cash and securities against $545.51M of debt, a net debt position of $389.35M.
Esperion Therapeutics pays dividends totaling $3.16 per share a year, a 99.37% yield at the Jul 14, 2026 close.
The share price is up 15.6% over the past year. At $3.18 (the Jul 14, 2026 close) it sits within its 52-week range of $1.80 to $4.17, above its 200-day moving average of $3.06.
Frequently Asked Questions About Esperion Therapeutics
What is the current stock price for ESPR?
As of the Jul 14, 2026 close, ESPR stock trades at $3.18. The 52-week range is $1.80–$4.18, with a day range of $3.18–$3.18.
What is the P/E ratio for ESPR?
The P/E ratio (Price-to-Earnings) for ESPR is shown in the Key Statistics section. This valuation metric helps compare Esperion Therapeutics, Inc. to industry peers.
Does ESPR pay dividends?
Yes, Esperion Therapeutics pays a 99.37% annual dividend yield as of the Jul 14, 2026 close ($3.16 per share a year). The most recent ex-dividend date was July 13, 2026.
What do analysts recommend for ESPR?
Analyst ratings and recommendations for ESPR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ESPR?
As of the Jul 14, 2026 close, Esperion Therapeutics's market capitalization is $799.3M, classifying it as a small-cap company. Esperion Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.